SBP Provides a Business Update and Files Report for Q3 2018

  • Sun BioPharma, Inc. opens third site in Melbourne, Australia in Front-Line Combination Study of SBP-101 with Gemcitabine and nab-Paclitaxel for the Treatment of Patients with Metastatic Pancreatic Cancer
  • Company announces leadership changes
  • Results of new pancreatitis study presented at American Pancreatic Association meeting

View/download press release »